# Intramyocardial Injection of Autologous Umbilical Cord Blood Derived Mononuclear Cells During Surgical Repair of Hypoplastic Left Heart Syndrome

> **NCT03779711** · PHASE2 · ACTIVE_NOT_RECRUITING · sponsor: **Timothy J Nelson, MD, PhD** · enrollment: 95 (actual)

## Conditions studied

- Hypoplastic Left Heart Syndrome

## Interventions

- **BIOLOGICAL:** Autologous (self) mononuclear cells derived from umbilical cord blood
- **PROCEDURE:** Stage II Surgical repair

## Key facts

- **NCT ID:** NCT03779711
- **Lead sponsor:** Timothy J Nelson, MD, PhD
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2019-06-06
- **Primary completion:** 2022-05-22
- **Final completion:** 2026-02
- **Target enrollment:** 95 (ACTUAL)
- **Last updated:** 2025-07-08

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03779711

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03779711, "Intramyocardial Injection of Autologous Umbilical Cord Blood Derived Mononuclear Cells During Surgical Repair of Hypoplastic Left Heart Syndrome". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT03779711. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*